News

Hearing the words “you have cancer” can feel like the ground has shifted beneath you. Even before treatment begins, many people experience fear, worry, sadness, or a sense of being overwhelmed. Appointments, test results, side effects, and changes to daily life can take an emotional toll. While family and friend support is incredibly important, it’s okay to need more. Taking care of your mental and emotional health is a meaningful part of healing. At Karmanos Cancer Institute locations across McLaren He...

MD/alert Suresh Balasubramanian, M.D. , hematologist and medical oncologist, and member of the  Hematology Oncology  and  Multiple Myeloma and Amyloidosis  Multidisciplinary Teams at Karmanos, discussed the latest survival data from the PATHFINDER study, investigating the use of the targeted inhibitor KIT D816V. He explained how this therapy has transformed the treatment of systemic mastocytosis. Watch the interview here .

Patient Power What is anticipatory grief? It’s grief that can occur before the loss of a loved one. Mary Morreale, M.D. , clinical psychiatrist and member of the  Supportive Oncology Multidisciplinary Team  at Karmanos, shared how feeling this grief can produce anxiety, how it differs from traditional grief, and how caregivers, family and friends can seek help. Read the article here .

Patient Power Nancie Petrucelli, MS, LCGC , licensed senior genetic counselor and director of the Karmanos Cancer Genetic Counseling Service , explained what genetic counseling is and how knowing which mutations a patient may have can assist with screening and prevention options to help catch cancer early or reduce cancer risk. Read the article here .

FOX 2 A researcher and his team in Spain have identified a combination of drug therapies that is showing promise in pre-clinical studies for treating pancreatic cancer. Asfar Azmi, Ph.D., scientist, director of the Pancreatic Cancer Research Initiative and member of the  Molecular Therapeutics Research Program  at Karmanos, joined FOX 2 to talk about this new discovery, what it means for patients, and how he, his team, and other Karmanos colleagues are studying this disease. Dr. Azmi also shar...

The Karmanos Cancer Network and the McLaren Center for Research and Innovation (MCRI) have officially partnered on their first collaborative research study spanning both oncology and non-oncology research sites. The project, Ask Questions About Clinical Trials (ASQ CT), marks a significant milestone in integrating research efforts across McLaren Health Care and reflects a shared commitment to improving patient-centered communication about clinical trials. Led by Lauren Hamel, Ph.D., MBA, co-leader of th...

Patient Power Suresh Balasubramanian, M.D. , hematologist and medical oncologist, and member of the  Hematology Oncology  and  Multiple Myeloma and Amyloidosis  Multidisciplinary Teams at Karmanos, disclosed some risks and side effects of taking steroids as part of the treatment plan for systemic mastocytosis, additional therapies that can be used instead of or to complement the steroid treatment, and when patients should let their physician know they may be experiencing side effects...

WWJ The human papillomavirus (HPV) causes many cancers – one of those is cervical cancer. Radhika Gogoi, M.D., Ph.D. , gynecologic oncologist and member of the  Gynecologic Oncology Multidisciplinary Team  at Karmanos, explained the virus, the cancers that are linked to HPV, and shared the research she conducted on cervical cancer patients’ knowledge of HPV and the vaccine. Hear why Dr. Gogoi said cervical cancer could be a cancer that could eventually be eradicated. Listen here .

Cure With advances in technology, decentralized trials are becoming a more viable option for some clinical trials. Jeffrey Zonder, M.D. , hematologist and leader of the  Multiple Myeloma and Amyloidosis Multidisciplinary Team , led the first decentralized trial at Karmanos. He shared how to determine if elements of some clinical studies can be safely moved to a virtual format. Read the article here .

McLaren Health Care has presented its annual President’s Trophy to Karmanos Cancer Institute, recognizing the Detroit-based, nationally renowned cancer center with the statewide health care system’s most prestigious honor as its top-performing subsidiary. Karmanos earned this celebrated recognition through its teams’ performance in vital clinical quality and patient safety metrics, while also accounting for patient experience and satisfaction, operational excellence, research impact, and financial stewa...